Press release
High Potent Medicines Conference | Presentation by Global Speaker
Welcome to the MarketsandMarkets 9th High Potent Medicines Conference- the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). This transformative event converges industry leaders and regulatory professionals on a singular platform dedicated to exploring cutting-edge developments in the development, manufacturing, and safe handling of highly potent compounds.Register Now @ https://events.marketsandmarkets.com/high-potent-medicines-conference-eu-edition/register
Key Highlights:-
• Technology transfer and scale up of HPAPI's
• Right CDMO selection and partnership
• Containment and handling of HPAPI's
• Cleaning validation and risk mitigation
• Regulatory landscape and compliance
• Occupational Health and Safety
Why Attend-
• Utilizing the best practices to ensure safe and efficient production of high potent medicines
• Training sessions on complex high potent compounds handling and containment issues
• Understanding the updated regulatory guidelines in the HPAPI process
• Implementing response plans to react to an unplanned event
• Knowing the outsourcing strategies to effectively build a reliable supply chain
Become a Speaker @ https://events.marketsandmarkets.com/high-potent-medicines-conference-eu-edition/speaker-enquiry
ADDRESS:
Magarpatta City, Hadapsar, Pune, India - 411013
About Us:-
MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High Potent Medicines Conference | Presentation by Global Speaker here
News-ID: 3452191 • Views: …
More Releases from MNMConferences
Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg, G …
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany.
Register Now @ https://events.marketsandmarkets.com/immunobio-series/register
Dive deep into the convergence of biomarkers and immuno-oncology at our flagship conference, where industry pioneers, thought leaders, and experts converge to drive innovation in healthcare and biotechnology. This transformative event offers a dynamic platform for collaboration, knowledge…
Upcoming Event on 'Orphan Drugs and Rare Diseases Conference - US Edition' | 17t …
Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development.
The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare…
Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg im …
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg im Breisgau, Germany.
Dive deep into the convergence of biomarkers and immuno-oncology at our flagship conference, where industry pioneers, thought leaders, and experts converge to drive innovation in healthcare and biotechnology. This transformative event offers a dynamic platform for collaboration, knowledge exchange, and…
MarketsandMarkets Probiotics Conference | 24th - 25th October 2024 | London, UK
The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the human microbiome's influence on health and the environment. Discover the latest breakthroughs in microbiome therapies and probiotics, all while tackling challenges such as limited research and regulatory intricacies. Engage with industry experts across various sectors to gain valuable insights into microbial innovation, regulatory pathways, and…
More Releases for HPAPI
Cytotoxic Drugs and HPAPI Manufacturing Market
Cytotoxic Drugs and HPAPI Manufacturing Market worth $27.1 Bn by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Cytotoxic Drugs and HPAPI Manufacturing Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large, Very Large), Scale of Operation (Preclinical, clinical, commercial), Type of Molecule (Small molecules, biologics), Type of Highly Potent…
HPAPI Market Player Profiling, Forecast till 2028
According to Ameco Research 'HPAPI Market report, the analysts took this into account when estimating the HPAPI Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the HPAPI Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes HPAPI Market trends, segmentation, key companies, SWOT, PORTER and…
HPAPI Market Size Forecast till 2028
According to Ameco Research 'HPAPI Market report, the analysts took this into account when estimating the HPAPI Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the HPAPI Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes HPAPI Market trends, segmentation, key companies, SWOT, PORTER and…
HPAPI Market: Opportunities and Challenges
The global HPAPIs Market is projected to register a CAGR of 8.7% during the forecast period (2018-23). The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies and growing focus on precision medicine. However, factors such as the requirement of large investments, discrepancies in HPAPI banding…
New Technologies for HPAPI Manufacturing and Containment
SMI Reports: With new technologies becoming available for the pharmaceutical industry, the HPAPI market is utilising these new innovations to simplify manufacturing processes reducing powder exposure and allowing a semi-continuous production.
At this year's HPAPI USA Conference emerging manufacturing technologies will be one of the key points to be discussed along with containment issues, disaster management, Oncology Antibody-Drug Conjugates (ADCs) and staff training procedures.
Key highlights include:
Alternative HPAPI manufacturing technologies to…
The Latest Innovations in HPAPI Manufacturing Technologies
SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on effective and safe containment solutions for biologics based HPAPIs, along with cleaning and cross contamination requirements.
Keith Jensen, Owner and Consultant at Keith Jensen Consulting, previously at Novartis-MIT Center for Continuous Manufacturing, discusses alternative HPAPI manufacturing technologies to reduce powder exposure and improve safety enabling continuous manufacturing. Other…
